RxDoctor Payments Data

Mary Garrett, PA

Physician Assistant · Batavia, OHNPI 1629587829

Payments from drug & device makers

$4,139in general payments, 2019–2025

Across 149 payments — averaging $27.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$731
  • Astellas Pharma US Inc$697
  • Teleflex LLC$447
  • Medtronic$368
  • Boston Scientific$200
  • Axonics, Inc.$171
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$3,95496%
  • Education$1854%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,139 in reported general payments places this provider in the 90th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Medicare billing

Part B allowed, 2024
$62,949
Medicare patients
309
Services billed
1,416

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron69$41,612
GemtesaVibegron15$21,588
Testosterone Cypionate94$4,789
Testosterone20$3,704
Estradiol25$1,778
Tamsulosin Hcl163$1,620
Cephalexin64$471
Finasteride26$374
Oxybutynin Chloride25$355
CefuroximeCefuroxime Axetil15$301
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst23$251
Imipramine Hcl13$140
Anastrozole36$86
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$79
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$56

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$697$41,61269 claims
Sumitomo Pharma America, Inc.Gemtesa$731$21,58815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Batavia

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →